Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Doseområde Funnstudie For å vurdere effektivitet og sikkerhet for Tozorakimab hos voksne med ukontrollert astma på mellomstore til høy dose inhalerte kortikosteroider (Umbriel)

29. oktober 2026 oppdatert av: AstraZeneca

En fase IIB, multisenter, dobbeltblind, placebokontrollert doseområde Funnstudie for å vurdere effekt og sikkerhet for Tozorakimab hos voksne deltakere med ukontrollert astma på middels til høy dose inhalerte kortikosteroider

This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

Studieoversikt

Status

Rekruttering

Forhold

Studietype

Intervensjonell

Registrering (Antatt)

540

Fase

  • Fase 2

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • CABA, Argentina, C1425BEN
        • Rekruttering
        • Research Site
      • Ciudad de Buenos Aires, Argentina, 1128
        • Tilbaketrukket
        • Research Site
      • Ciudad de Buenos Aires, Argentina, 1425
        • Rekruttering
        • Research Site
      • La Plata, Argentina, B1900
        • Rekruttering
        • Research Site
      • Mendoza, Argentina, 5500
        • Rekruttering
        • Research Site
      • Rosario, Argentina, 2000
        • Rekruttering
        • Research Site
      • San Miguel de Tucumán, Argentina, 4000
        • Rekruttering
        • Research Site
      • Caxias do Sul, Brasil, 95070-560
        • Tilbaketrukket
        • Research Site
      • Criciúma, Brasil, 88811-000
        • Rekruttering
        • Research Site
      • Porto Alegre, Brasil, 91350-200
        • Rekruttering
        • Research Site
      • Porto Alegre, Brasil, 90610-001
        • Rekruttering
        • Research Site
      • Salvador, Brasil, 40050 410
        • Tilbaketrukket
        • Research Site
      • Santo André, Brasil, 09080-110
        • Tilbaketrukket
        • Research Site
      • Sorocaba, Brasil, 18040-425
        • Rekruttering
        • Research Site
      • São José do Rio Preto, Brasil, 15090-000
        • Rekruttering
        • Research Site
      • São Paulo, Brasil, 05403-000
        • Rekruttering
        • Research Site
      • São Paulo, Brasil, 04014-002
        • Rekruttering
        • Research Site
      • Curicó, Chile, 3341643
        • Aktiv, ikke rekrutterende
        • Research Site
      • Quillota, Chile, 2260000
        • Aktiv, ikke rekrutterende
        • Research Site
      • Santiago, Chile, 7500657
        • Aktiv, ikke rekrutterende
        • Research Site
      • Santiago, Chile, 7501126
        • Aktiv, ikke rekrutterende
        • Research Site
      • Santiago, Chile, 7750495
        • Aktiv, ikke rekrutterende
        • Research Site
      • Temuco, Chile, 4810345
        • Aktiv, ikke rekrutterende
        • Research Site
      • Viña del Mar, Chile, 2540488
        • Aktiv, ikke rekrutterende
        • Research Site
      • Iloilo City, Filippinene, 5000
        • Rekruttering
        • Research Site
      • Las Piñas, Filippinene, 1742
        • Tilbaketrukket
        • Research Site
      • Lipa, Filippinene, 4217
        • Rekruttering
        • Research Site
      • Manadaluyong City, Filippinene, 1552
        • Rekruttering
        • Research Site
      • Quezon City, Filippinene, 1100
        • Rekruttering
        • Research Site
      • Roxas City, Filippinene, 5800
        • Tilbaketrukket
        • Research Site
    • California
      • Bakersfield, California, Forente stater, 93301
        • Rekruttering
        • Research Site
      • Huntington Beach, California, Forente stater, 92647
        • Tilbaketrukket
        • Research Site
      • La Mesa, California, Forente stater, 91942
        • Avsluttet
        • Research Site
      • Loma Linda, California, Forente stater, 92354
        • Tilbaketrukket
        • Research Site
      • Long Beach, California, Forente stater, 90815
        • Rekruttering
        • Research Site
      • Newport Beach, California, Forente stater, 92663
        • Rekruttering
        • Research Site
      • San Jose, California, Forente stater, 95117
        • Rekruttering
        • Research Site
    • Delaware
      • Wilmington, Delaware, Forente stater, 19805
        • Avsluttet
        • Research Site
    • Florida
      • Cutler Bay, Florida, Forente stater, 33189
        • Suspendert
        • Research Site
      • Hialeah, Florida, Forente stater, 33015
        • Suspendert
        • Research Site
      • Leesburg, Florida, Forente stater, 34748
        • Tilbaketrukket
        • Research Site
      • Miami, Florida, Forente stater, 33175
        • Suspendert
        • Research Site
      • Miami, Florida, Forente stater, 33155
        • Suspendert
        • Research Site
      • Miami Lakes, Florida, Forente stater, 33016
        • Suspendert
        • Research Site
      • Orlando, Florida, Forente stater, 32819
        • Suspendert
        • Research Site
      • Palmetto Bay, Florida, Forente stater, 33157
        • Suspendert
        • Research Site
      • Tampa, Florida, Forente stater, 33607
        • Suspendert
        • Research Site
      • Winter Park, Florida, Forente stater, 32789
        • Suspendert
        • Research Site
    • Idaho
      • Boise, Idaho, Forente stater, 83706
        • Tilbaketrukket
        • Research Site
    • Indiana
      • Noblesville, Indiana, Forente stater, 46060
        • Rekruttering
        • Research Site
    • Iowa
      • West Des Moines, Iowa, Forente stater, 50266
        • Avsluttet
        • Research Site
    • Kansas
      • Hutchinson, Kansas, Forente stater, 67502
        • Rekruttering
        • Research Site
      • Kansas City, Kansas, Forente stater, 66160
        • Tilbaketrukket
        • Research Site
    • Kentucky
      • Louisville, Kentucky, Forente stater, 40218
        • Rekruttering
        • Research Site
    • Maryland
      • White Marsh, Maryland, Forente stater, 21162
        • Tilbaketrukket
        • Research Site
    • Massachusetts
      • Worcester, Massachusetts, Forente stater, 01605
        • Rekruttering
        • Research Site
    • Michigan
      • Farmington Hills, Michigan, Forente stater, 48336
        • Rekruttering
        • Research Site
      • Warren, Michigan, Forente stater, 48088
        • Tilbaketrukket
        • Research Site
    • Missouri
      • St Louis, Missouri, Forente stater, 63141
        • Tilbaketrukket
        • Research Site
    • Nebraska
      • Bellevue, Nebraska, Forente stater, 68123
        • Tilbaketrukket
        • Research Site
      • Grand Island, Nebraska, Forente stater, 68803
        • Rekruttering
        • Research Site
      • Omaha, Nebraska, Forente stater, 68134
        • Rekruttering
        • Research Site
    • New Jersey
      • Millville, New Jersey, Forente stater, 08332
        • Har ikke rekruttert ennå
        • Research Site
      • Mullica Hill, New Jersey, Forente stater, 08062
        • Rekruttering
        • Research Site
      • Toms River, New Jersey, Forente stater, 08755
        • Rekruttering
        • Research Site
    • New York
      • Horseheads, New York, Forente stater, 14845
        • Rekruttering
        • Research Site
      • Maspeth, New York, Forente stater, 11378
        • Rekruttering
        • Research Site
    • North Carolina
      • Asheville, North Carolina, Forente stater, 28803
        • Tilbaketrukket
        • Research Site
      • Huntersville, North Carolina, Forente stater, 28078
        • Tilbaketrukket
        • Research Site
      • Kings Mountain, North Carolina, Forente stater, 28086
        • Rekruttering
        • Research Site
      • Pinehurst, North Carolina, Forente stater, 28374
        • Tilbaketrukket
        • Research Site
    • Ohio
      • Toledo, Ohio, Forente stater, 43617
        • Rekruttering
        • Research Site
    • Oklahoma
      • Edmond, Oklahoma, Forente stater, 73034
        • Tilbaketrukket
        • Research Site
    • Oregon
      • Grants Pass, Oregon, Forente stater, 97527
        • Tilbaketrukket
        • Research Site
      • Medford, Oregon, Forente stater, 97504
        • Rekruttering
        • Research Site
      • Portland, Oregon, Forente stater, 97202
        • Rekruttering
        • Research Site
    • Pennsylvania
      • DuBois, Pennsylvania, Forente stater, 15801
        • Avsluttet
        • Research Site
      • Philadelphia, Pennsylvania, Forente stater, 19140
        • Rekruttering
        • Research Site
      • Smithfield, Pennsylvania, Forente stater, 15478
        • Rekruttering
        • Research Site
    • South Carolina
      • Rock Hill, South Carolina, Forente stater, 29732
        • Rekruttering
        • Research Site
    • Tennessee
      • Knoxville, Tennessee, Forente stater, 37919
        • Avsluttet
        • Research Site
    • Texas
      • Austin, Texas, Forente stater, 78759
        • Rekruttering
        • Research Site
      • Boerne, Texas, Forente stater, 78006
        • Rekruttering
        • Research Site
      • Dallas, Texas, Forente stater, 75254
        • Rekruttering
        • Research Site
      • El Paso, Texas, Forente stater, 79912
        • Rekruttering
        • Research Site
      • Forney, Texas, Forente stater, 75126
        • Avsluttet
        • Research Site
      • Greenville, Texas, Forente stater, 75401
        • Rekruttering
        • Research Site
      • Kingwood, Texas, Forente stater, 77339
        • Rekruttering
        • Research Site
      • McKinney, Texas, Forente stater, 75069
        • Tilbaketrukket
        • Research Site
      • Sugar Land, Texas, Forente stater, 77478
        • Rekruttering
        • Research Site
      • Victoria, Texas, Forente stater, 77901
        • Rekruttering
        • Research Site
    • Utah
      • Roy, Utah, Forente stater, 84067
        • Avsluttet
        • Research Site
    • Washington
      • Bellingham, Washington, Forente stater, 98225
        • Avsluttet
        • Research Site
    • West Virginia
      • Kingwood, West Virginia, Forente stater, 26537
        • Rekruttering
        • Research Site
    • Wisconsin
      • Milwaukee, Wisconsin, Forente stater, 53228
        • Rekruttering
        • Research Site
      • Brest, Frankrike, 29200
        • Rekruttering
        • Research Site
      • Créteil, Frankrike, 94010
        • Rekruttering
        • Research Site
      • Lyon, Frankrike, 69317
        • Rekruttering
        • Research Site
      • Marseille, Frankrike, 13015
        • Rekruttering
        • Research Site
      • Pessac, Frankrike, 33604
        • Rekruttering
        • Research Site
      • Strasbourg, Frankrike, 67091
        • Rekruttering
        • Research Site
      • Suresnes, Frankrike, 92150
        • Rekruttering
        • Research Site
      • Athens, Hellas, 11521
        • Aktiv, ikke rekrutterende
        • Research Site
      • Athens, Hellas, 17562
        • Aktiv, ikke rekrutterende
        • Research Site
      • Ioannina, Hellas, 45500
        • Tilbaketrukket
        • Research Site
      • Pátrai, Hellas, 26504
        • Aktiv, ikke rekrutterende
        • Research Site
      • Thessaloniki, Hellas, 57010
        • Aktiv, ikke rekrutterende
        • Research Site
      • Thessaloniki, Hellas, 57001
        • Suspendert
        • Research Site
      • Belagavi, India, 590010
        • Rekruttering
        • Research Site
      • Coimbatore, India, 641028
        • Rekruttering
        • Research Site
      • Dehradun, India, 248001
        • Rekruttering
        • Research Site
      • Delhi, India, 110029
        • Rekruttering
        • Research Site
      • Faridabad, India, 121012
        • Tilbaketrukket
        • Research Site
      • Gūrgaon, India, 122001
        • Tilbaketrukket
        • Research Site
      • Kochi, India, 682027
        • Avsluttet
        • Research Site
      • Lucknow, India, 226003
        • Suspendert
        • Research Site
      • New Delhi, India, 110005
        • Rekruttering
        • Research Site
      • Vadodara, India, 391760
        • Rekruttering
        • Research Site
      • Haifa, Israel, 3109601
        • Rekruttering
        • Research Site
      • Jerusalem, Israel, 91120
        • Rekruttering
        • Research Site
      • Kfar Saba, Israel, 44281
        • Rekruttering
        • Research Site
      • Ramat Gan, Israel, 52621
        • Rekruttering
        • Research Site
      • Rehovot, Israel, 76100
        • Rekruttering
        • Research Site
      • Catania, Italia, 95123
        • Rekruttering
        • Research Site
      • Foggia, Italia, 71100
        • Rekruttering
        • Research Site
      • Genoa, Italia, 16132
        • Rekruttering
        • Research Site
      • Roma, Italia, 00168
        • Rekruttering
        • Research Site
      • Fukuoka, Japan, 811-1394
        • Rekruttering
        • Research Site
      • Ginowan-shi, Japan, 901-2214
        • Rekruttering
        • Research Site
      • Hiroshima, Japan, 730-0013
        • Rekruttering
        • Research Site
      • Ishinomaki, Japan, 986-8522
        • Rekruttering
        • Research Site
      • Kawaguchi-shi, Japan, 332-8558
        • Rekruttering
        • Research Site
      • Kiyose-shi, Japan, 204-8585
        • Rekruttering
        • Research Site
      • Kobe, Japan, 650-0017
        • Rekruttering
        • Research Site
      • Meguro-ku, Japan, 152-8902
        • Rekruttering
        • Research Site
      • Miura, Japan, 238-0111
        • Rekruttering
        • Research Site
      • Neyagawa, Japan, 572-8551
        • Rekruttering
        • Research Site
      • Sapporo, Japan, 064-0804
        • Rekruttering
        • Research Site
      • Sapporo, Japan, 060-0033
        • Rekruttering
        • Research Site
      • Takamatsu, Japan, 761-8073
        • Rekruttering
        • Research Site
      • Ube, Japan, 755-8505
        • Rekruttering
        • Research Site
      • Yokohama, Japan, 232-0066
        • Rekruttering
        • Research Site
      • Yokohama, Japan, 245-8575
        • Rekruttering
        • Research Site
      • Yokohama, Japan, 232-0024
        • Rekruttering
        • Research Site
      • Baotou, Kina, 014010
        • Rekruttering
        • Research Site
      • Changchun, Kina, 130021
        • Rekruttering
        • Research Site
      • Chengdu, Kina, 610000
        • Rekruttering
        • Research Site
      • Chongqing, Kina, 400010
        • Rekruttering
        • Research Site
      • Guangzhou, Kina, 510163
        • Rekruttering
        • Research Site
      • Haikou, Kina, 570311
        • Rekruttering
        • Research Site
      • Hefei, Kina, 230061
        • Rekruttering
        • Research Site
      • Hohhot, Kina, 10050
        • Rekruttering
        • Research Site
      • Huizhou, Kina, 516001
        • Rekruttering
        • Research Site
      • Qingdao, Kina, 266011
        • Rekruttering
        • Research Site
      • Shanghai, Kina, 200025
        • Rekruttering
        • Research Site
      • Shanghai, Kina, 200065
        • Rekruttering
        • Research Site
      • Shanghai, Kina, 201114
        • Rekruttering
        • Research Site
      • Shenzhen, Kina, 518020
        • Rekruttering
        • Research Site
      • Wenzhou, Kina, 325027
        • Rekruttering
        • Research Site
      • Xuzhou, Kina, 221000
        • Rekruttering
        • Research Site
      • Lima, Peru, 15046
        • Aktiv, ikke rekrutterende
        • Research Site
      • Lima, Peru, LIMA 21
        • Tilbaketrukket
        • Research Site
      • Lima, Peru, 15088
        • Aktiv, ikke rekrutterende
        • Research Site
      • Lima, Peru, LIMA 33
        • Tilbaketrukket
        • Research Site
      • Lima, Peru, 15082
        • Aktiv, ikke rekrutterende
        • Research Site
      • Lima, Peru, LIMA 1
        • Aktiv, ikke rekrutterende
        • Research Site
      • Barcelona, Spania, 08003
        • Rekruttering
        • Research Site
      • Barcelona, Spania, 8025
        • Rekruttering
        • Research Site
      • Madrid, Spania, 28041
        • Rekruttering
        • Research Site
      • Málaga, Spania, 29010
        • Rekruttering
        • Research Site
      • Mérida, Spania, 06800
        • Tilbaketrukket
        • Research Site
      • Patraix, Spania, 46017
        • Rekruttering
        • Research Site
      • Santander, Spania, 39008
        • Rekruttering
        • Research Site
      • Cheongju-si, Sør -Korea, 28644
        • Aktiv, ikke rekrutterende
        • Research Site
      • Daegu, Sør -Korea, 42415
        • Aktiv, ikke rekrutterende
        • Research Site
      • Seoul, Sør -Korea, 03080
        • Rekruttering
        • Research Site
      • Seoul, Sør -Korea, 03722
        • Aktiv, ikke rekrutterende
        • Research Site
      • Seoul, Sør -Korea, 08308
        • Aktiv, ikke rekrutterende
        • Research Site
      • Seoul, Sør -Korea, 05505
        • Aktiv, ikke rekrutterende
        • Research Site
      • Seoul, Sør -Korea, 03312
        • Aktiv, ikke rekrutterende
        • Research Site
      • Seoul, Sør -Korea, 06591
        • Fullført
        • Research Site
      • Bellville, Sør-Afrika, 7530
        • Rekruttering
        • Research Site
      • Benoni, Sør-Afrika, 1501
        • Rekruttering
        • Research Site
      • Brackenfell, Sør-Afrika, 7560
        • Rekruttering
        • Research Site
      • Cape Town, Sør-Afrika, 7700
        • Rekruttering
        • Research Site
      • Durban, Sør-Afrika, 4093
        • Rekruttering
        • Research Site
      • Somerset West, Sør-Afrika, 7130
        • Rekruttering
        • Research Site
      • eMkhomazi, Sør-Afrika, 4170
        • Rekruttering
        • Research Site
      • Kaohsiung City, Taiwan, 80756
        • Rekruttering
        • Research Site
      • New Taipei City, Taiwan, 231
        • Tilbaketrukket
        • Research Site
      • Taichung, Taiwan, 40705
        • Rekruttering
        • Research Site
      • Taichung, Taiwan, 433004
        • Rekruttering
        • Research Site
      • Taipei, Taiwan, 10002
        • Rekruttering
        • Research Site
      • Taipei, Taiwan, 11220
        • Rekruttering
        • Research Site
      • Taipei, Taiwan, 110
        • Rekruttering
        • Research Site
      • Taipei, Taiwan, 11696
        • Rekruttering
        • Research Site
      • Bangkok, Thailand, 10700
        • Rekruttering
        • Research Site
      • Chanthaburi, Thailand, 22000
        • Rekruttering
        • Research Site
      • Chiang Rai, Thailand, 57000
        • Rekruttering
        • Research Site
      • Chon Buri, Thailand, 20000
        • Rekruttering
        • Research Site
      • Khon Kaen, Thailand, 40002
        • Rekruttering
        • Research Site
      • Nakhon Sri Thammarat, Thailand, 80000
        • Rekruttering
        • Research Site
      • Adana, Tyrkia (Türkiye), 01330
        • Rekruttering
        • Research Site
      • Ankara, Tyrkia (Türkiye), 06280
        • Rekruttering
        • Research Site
      • Bursa, Tyrkia (Türkiye), 16059
        • Rekruttering
        • Research Site
      • Gaziantep, Tyrkia (Türkiye), 27470
        • Rekruttering
        • Research Site
      • Istanbul, Tyrkia (Türkiye), 34890
        • Rekruttering
        • Research Site
      • Kayseri, Tyrkia (Türkiye), 38039
        • Rekruttering
        • Research Site
      • Mersin, Tyrkia (Türkiye), 33079
        • Rekruttering
        • Research Site
      • Balassagyarmat, Ungarn, 2660
        • Aktiv, ikke rekrutterende
        • Research Site
      • Budapest, Ungarn, 1121
        • Tilbaketrukket
        • Research Site
      • Budapest, Ungarn, 1036
        • Tilbaketrukket
        • Research Site
      • Debrecen, Ungarn, 4032
        • Aktiv, ikke rekrutterende
        • Research Site
      • Gödöllő, Ungarn, 2100
        • Aktiv, ikke rekrutterende
        • Research Site
      • Pécs, Ungarn, 7635
        • Aktiv, ikke rekrutterende
        • Research Site
      • Törökbálint, Ungarn, 2045
        • Aktiv, ikke rekrutterende
        • Research Site
      • Da Nang, Vietnam, 550000
        • Rekruttering
        • Research Site
      • Haiphong, Vietnam, 180000
        • Rekruttering
        • Research Site
      • Hanoi, Vietnam, 100000
        • Rekruttering
        • Research Site
      • Ho Chi Minh City, Vietnam, 700000
        • Rekruttering
        • Research Site
      • Ho Chi Minh City, Vietnam, 700000
        • Tilbaketrukket
        • Research Site
      • Ho Chi Minh City, Vietnam, 10000
        • Rekruttering
        • Research Site
      • Huế, Vietnam, 530000
        • Rekruttering
        • Research Site

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 75 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Provision of signed and dated written informed consent prior to any study-specific procedures.

  2. Adults aged 18-75, inclusive when signing the informed consent.

  3. Documented physician-diagnosis of asthma for at least 12 months.

  4. Treated with medium or high dose ICS in combination with LABA.

  5. Demonstration of uncontrolled asthma through ACQ-6 score ≥ 1.5 .

  6. Pre-bronchodilator FEV1 ≥ 40% to ≤ 90% of predicted normal.

  7. Documented exacerbation history in the last 12 months and biomarker requirements of:

    1. ≥ 2 severe exacerbations OR
    2. 1 severe exacerbation and:

    (i) Eosinophils ≥ 150 cells/µl or (ii) FeNo ≥ 25 ppb

  8. Participants need to demonstrate a ≥70% compliance for Asthma Daily Diary.

  9. Women of Child Bearing Potential (WOCBP) must have a negative pregnancy test.

  10. Contraceptive use by males and females should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.

Exclusion Criteria:

  1. Completed treatment for respiratory infection with antibiotics in the 4 weeks prior to Visit 1.
  2. Clinically significant pulmonary disease other than asthma .
  3. Current smokers, former smokers with >10 pack-years history.
  4. Clinically significant aortic stenosis or pulmonary arterial hypertension.
  5. Active tuberculosis, hepatitis, HIV, or current diagnosis of cancer or immune complex disease.
  6. Unstable cardiovascular disorders.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Firemannsrom

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Tozorakimab Dose 1

Dosing subcutaneously tozorakimab Dose 1

The drug will be administered subcutaneously.

Eksperimentell: Tozorakimab Dose 2

Dosing subcutaneously tozorakimab Dose 2 and placebo

The drug will be administered subcutaneously.

Placebo komparator: Placebo

Dosing subcutaneously with equivalent volume to tozorakimab

Placebo will be administered subcutaneously.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Annualised rate of severe asthma exacerbations
Tidsramme: Over 26 to 52 weeks

The rate ratio of severe asthma exacerbations will be assessed in the participants with uncontrolled moderate-to-severe asthma and ≥ 1 severe exacerbation within 12 months prior to screening.

Over 26 to 52 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Annualised rate of severe asthma exacerbations
Tidsramme: Over 26 to 52 weeks

The rate ratio of severe asthma exacerbations will be assessed in the participants with uncontrolled moderate-to-severe asthma and baseline eosinophils < 300 cells/µL and history of ≥2 severe exacerbations within 12 months prior to screening.

Over 26 to 52 weeks
Time to first severe asthma exacerbation
Tidsramme: Over 26 to 52 weeks

To evaluate the effect of two dose levels of tozorakimab compared to placebo on time to first severe asthma exacerbations.

Over 26 to 52 weeks
Change from baseline in pre-bronchodilator forced expiratory volume in 1 second (FEV1)
Tidsramme: Over weeks 20 to 26

Difference in mean change from baseline between tozorakimab and placebo.

Over weeks 20 to 26
Change from baseline in post-bronchodilator FEV1
Tidsramme: At week 26

Difference in mean change from baseline between tozorakimab and placebo.

At week 26
Change from baseline in the Asthma Control Questionnaire 6 (ACQ-6)
Tidsramme: At week 26

Difference in mean change from baseline between tozorakimab and placebo. The ACQ-6 has 6 questions (regarding asthma symptoms and rescue bronchodilator use). Answering the questions results in a score out of 6. A Score of 0 indicates complete control and 6 reflects severely uncontrolled disease.

At week 26
Change from baseline in the Asthma Quality of Life Questionnaire for 12 Years and Older (AQLQ12+)
Tidsramme: At week 26

Difference in mean change from baseline between tozorakimab and placebo. The AQLQ12+ includes 32 questions grouped into four domains: symptoms; activity limitations; emotional function; and, environmental stimuli. Each question is scored on a seven-point Likert scale, which ranges from 7 (no impairment) to 1 (severe impairment). The overall score is calculated as the mean of all questions, and the four domain scores are the means of the scores for the questions in the respective domains.

At week 26
Trough serum concentrations of tozorakimab
Tidsramme: Over 52 weeks

Pharmacokinetics: concentrations of tozorakimab in trough serum.

Over 52 weeks
Anti-drug antibody incidence
Tidsramme: Over 52 weeks

Immunogenicity: Number of Participants With Positive Antibodies to tozorakimab

Over 52 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

26. mars 2025

Primær fullføring (Antatt)

7. juni 2027

Studiet fullført (Antatt)

28. februar 2028

Datoer for studieregistrering

Først innsendt

1. april 2025

Først innsendt som oppfylte QC-kriteriene

9. april 2025

Først lagt ut (Faktiske)

17. april 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

30. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

29. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • D9181C00002
  • 2024-519116-14-00 (Registeridentifikator: CTIS)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure. Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.

IPD-delingstidsramme

AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA PhRMA Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

Tilgangskriterier for IPD-deling

When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org.

Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere